• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Elucidation of Molecular Mechanisms of Epithelial-Mesenchymal Transition and Its Clinical Application in Triple-Negative Breast Cancer.

Research Project

Project/Area Number 25861160
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field General surgery
Research InstitutionKyushu University

Principal Investigator

YAMASHITA Nami  九州大学, 大学病院, 医員 (60608967)

Project Period (FY) 2013-04-01 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2014: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2013: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Keywordsトリプルネガティブ乳癌 / 上皮間葉系移行 / vimentin / E-cadherin / EMT / Axl / triple-negative乳癌 / basal-like乳癌
Outline of Final Research Achievements

The treatment of patients with TNBC has been challenging due to the absence of these molecular targets and the heterogeneity of the disease. The aim of our study is to elucidate the clinical importance of the expression of E-cadherin and vimentin in breast cancer.The elevated expression of vimentin contributes to the aggressive phenotype and poor prognosis in TNBC and basal-like breast cancer. Vimentin expression might be useful as a biomarker for the prognosis of TNBC. Also, co-expression of E-cadherin and vimentin seems to be associated with the most aggressive phenotype in breast cancer, and positive E-cadherin expression may not always play roles for tumor suppression. Vimentin and related molecule will be a good target to control the invasion and metastasis in TNBC.

Report

(3 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • Research Products

    (10 results)

All 2015 2014 2013

All Journal Article (3 results) (of which Peer Reviewed: 3 results,  Acknowledgement Compliant: 1 results) Presentation (7 results)

  • [Journal Article] Molecular mechanisms regulating the hormone sensitivity of breast cancer.2014

    • Author(s)
      Tokunaga E1, Hisamatsu Y, Tanaka K, Yamashita N, Saeki H, Oki E, Kitao H, Maehara Y.
    • Journal Title

      Cancer Sci.

      Volume: 105(11) Issue: 11 Pages: 1377-1377

    • DOI

      10.1111/cas.12521

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Acknowledgement Compliant
  • [Journal Article] Overexpression of metadherin/MTDH is associated with an aggressive phenotype and a poor prognosis in invasive breast cancer.2014

    • Author(s)
      Tokunaga E, Nakashima Y, Yamashita N, Hisamatsu Y, Okada S, Akiyoshi S, Aishima S, Kitao H, Morita M, Maehara Y.
    • Journal Title

      Breast Cancer

      Volume: 21 Issue: 3 Pages: 341-349

    • DOI

      10.1007/s12282-012-0398-2

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Vimentin as a poor prognostic factor for triple-negative breast cancer.2013

    • Author(s)
      Yamashita N, Tokunaga E, Kitao H, Hisamatsu Y, Taketani K, Akiyoshi S, Okada S, Aishima S, Morita M, Maehara Y.
    • Journal Title

      J Cancer Res Clin Oncol

      Volume: 139 Issue: 5 Pages: 739-746

    • DOI

      10.1007/s00432-013-1376-6

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Presentation] Clinical significance of co-expression of E-cadherin and vimentin in invasive breast cancer.2015

    • Author(s)
      Nami Yamashita, Eriko Tokunaga, Yuka Inoue, Kimihiro Tanaka, Yuichirou Nakashima, Kouji Ando, Kippei Ohgaki, Hiroshi Saeki, Eiji Oki, Yoshihiko Maehara
    • Organizer
      14 th St. Gallen International Breast Cancer Conference Primary Therapy of Early Breast Cancer
    • Place of Presentation
      Vienna
    • Year and Date
      2015-03-18 – 2015-03-21
    • Related Report
      2014 Annual Research Report
  • [Presentation] Significance of E-cadherin and vimentin expression in invasive breast cancer.2014

    • Author(s)
      Nami Yamashita, Eriko Tokunaga,Yuka Inoue, Kimihiro Tanaka, Yuichiro Nakashima,Kouji Ando, Kippei Ohgaki, Hiroshi Saeki, Eiji Oki, Yoshihiko Maehara
    • Organizer
      第73回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Year and Date
      2014-09-25 – 2014-09-27
    • Related Report
      2014 Annual Research Report
  • [Presentation] トリプルネガティブ乳癌におけるBRCA1機能不全の分子機序2014

    • Author(s)
      山下奈真、徳永えり子、武谷憲二、田中仁寛、安藤幸滋、木村和恵、佐伯浩司、沖 英次、森田勝、楠本哲也、前原喜彦
    • Organizer
      第21回日本乳癌学会学術総会
    • Place of Presentation
      大阪
    • Year and Date
      2014-07-10 – 2014-07-12
    • Related Report
      2014 Annual Research Report
  • [Presentation] The clinical importance of BRCA1 promoter methylation and LOH in breast cancer.2014

    • Author(s)
      Nami Yamashita, Eriko Tokunaga, Kimihiro Tanaka, Hiroyuki Kitao, Kouji Ando, Shuhei Ito, Hiroshi Saeki, Eiji Oki, Masaru Morita, Yoshihiko Maehara
    • Organizer
      第114回日本外科学会定期学術術集会
    • Place of Presentation
      京都
    • Year and Date
      2014-04-03 – 2014-04-05
    • Related Report
      2014 Annual Research Report
  • [Presentation] トリプルネガティブ乳癌の多様性とその分子機序2013

    • Author(s)
      山下奈真、徳永えり子、武谷憲二、安藤幸滋、木村和恵、佐伯浩司、沖 英次、
    • Organizer
      第113回日本外科学会定期学術集会
    • Place of Presentation
      福岡
    • Related Report
      2013 Research-status Report
  • [Presentation] Vimentin as a poor prognostic factor for triple negative breast cancer.2013

    • Author(s)
      Nami Yamashita, Eriko Tokunaga, Hiroyuki Kitao, Yuichi Hisamatsu, Kenji Taketani, Sayuri Akiyoshi, Satoko Okada, Shinichi Aishima, Masaru Morita, Yoshihiko Maehara
    • Organizer
      ASCO annual meeting 2013
    • Place of Presentation
      Chicago
    • Related Report
      2013 Research-status Report
  • [Presentation] トリプルネガティブ乳癌におけるvimentin発現の意義2013

    • Author(s)
      山下奈真、徳永えり子 、田中仁寛 、武谷憲二 、安藤幸滋、佐伯浩司 、沖英次、森田勝、前原喜彦
    • Organizer
      第22回日本がん転移学会学術集会・総会
    • Place of Presentation
      松本
    • Related Report
      2013 Research-status Report

URL: 

Published: 2014-07-25   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi